Introduction
Antithrombin, a member of the serpin superfamily of protein protease inhibitors, performs a key anticoagulant function in vertebrates by regulating the activity of blood coagulation cascade proteases [1, 2] . Antithrombin inhibits clotting proteases like other serpins by an unusual branched pathway suicide substrate mechanism. In this mechanism the serpin initially binds the protease through an exposed reactive center loop (RCL) as a regular substrate and proceeds to cleave the RCL to form the acylintermediate [3] . This cleavage triggers the suicide inactivation by inducing the metastable serpin to undergo a massive conformational change that deforms the protease catalytic machinery and kinetically traps the acyl-intermediate complex [4, 5] .
Antithrombin circulates in blood in a repressed reactivity state, but is activated by heparin and heparan sulfate glycosaminoglycans on the luminal and subluminal sides of blood vessels to control and localize the activity of blood coagulation proteases [6, 7] .
The glycosaminoglycans bind to antithrombin through a specific pentasaccharide sequence and induce allosteric activating changes which enable the serpin to inhibit coagulation proteases at a rapid, physiologically relevant rate [8, 9] . The activating conformational changes overcome the repressed reactivity state by relieving repulsive interactions that diminish favorable RCL and exosite interactions of the serpin with two target proteases, factor Xa and factor IXa [10] [11] [12] [13] [14] [15] . Heparin and heparan sulfate additionally enhance antithrombin reactivity with these proteases as well as with another target protease, thrombin, by a ternary complex bridging mechanism in which the binding of the protease to the glycosaminoglycan alongside antithrombin promotes the serpin-protease interaction [16] [17] [18] [19] [20] .
Rapid kinetic studies of heparin pentasaccharide binding to antithrombin have shown that allosteric activation is a two-step process in which the negatively charged pentasaccharide recognizes and binds to a positively charged site on the serpin and then induces the protein into an activated conformational state that is reported by CD, UV and fluorescence changes [9, 21] . Allosteric activation is driven by an induced-fit mechanism that shifts the protein into a higher energy activated state because of the increased pentasaccharide binding energy in this state [22, 23] . X-ray structures of free and pentasaccharide-complexed antithrombin have shown the nature of the allosteric activating changes produced by pentasaccharide binding and revealed that such changes involve both the heparin binding site and the protease binding site with an allosteric core mediating communication between these sites [24, 25] .
More recent studies have suggested that the allosteric activating changes that are initiated in the heparin binding site and propagated to the protease binding site may be resolvable into distinct steps. X-ray structures of an intermediate activated state of native antithrombin have thus been reported in which the conformational changes in the heparin binding site have occurred without the changes in the protease binding site [26, 27] . Our recent studies support such a two-stage allosteric activation mechanism in solution from our studies of conformationally altered latent and cleaved forms of antithrombin that have lost the ability to be activated as protease inhibitors but retain the ability to bind the heparin pentasaccharide [28] . These conformationally altered antithrombins thus bind the pentasaccharide through a two-step induced conformational change mechanism similar to that shown for the native antithrombin-pentasaccharide interaction, although with reduced affinity. Notably, an X-ray structure of latent antithrombin complexed with the pentasaccharide shows a remarkable resemblance to the intermediate native antithrombin-pentasaccharide complex in showing the same conformational changes in the heparin binding site without the global changes of fullyactivated native antithrombin [25] . Such findings suggest that pentasaccharide binding to the conformationally altered antithrombins may reflect an intermediate stage in the allosteric activation of native antithrombin. The present study was undertaken to assess whether the kinetics of pentasaccharide binding to native and latent antithrombins could be reconciled with a 3-step mechanism for allosteric activation of native antithrombin and allow dissection of the structural, spectroscopic and activating changes associated with each step of the 3-step mechanism.
Experimental
Simulations of pentasaccharide binding to native and latent forms of antithrombin by the 2-step mechanism of scheme 1 or the 3-step mechanism of scheme 2 were done by numerical integration of the differential equations for these mechanisms using Scientist software (Micromath) and the indicated values for K 1 , k +2 , k -2 , k +3 , and k -3 in Table 3 . These values were chosen based on apparent kinetic parameters obtained in kinetic studies of the binding interactions. For the initial binding step, the forward rate constant, k +1 , was set at the diffusion-limited value of 100 M Overlays of X-ray structures of antithrombin-heparin pentasaccharide complexes available from the Protein Data Bank and RMSD calculations were done using Swiss PDB viewer software.
Results and Discussion

Kinetics of pentasaccharide binding to native and conformationally altered
antithrombins-The kinetics of heparin pentasaccharide binding to native antithrombin monitored by intrinsic tryptophan or bound TNS fluorescence changes that report the binding show a saturable dependence of the observed pseudo-first order binding rate constant on heparin concentration. This dependence is indicative of a two-step induced conformational change binding mechanism in which the pentasaccharide binds to antithrombin in an initial rapid equilibrium step characterized by a dissociation constant, K 1 , and then induces a conformational change in the protein with forward and reverse rate constants, k +2 and k -2 (Scheme 1) [21] . This latter step is reported by protein or TNS fluorescence changes.
That the first binding step is in rapid equilibrium is supported by the observation that progress curves for heparin pentasaccharide binding to native antithrombin show no lags over a wide range of saccharide concentrations [21] . Surprisingly, the kinetics of 
Three-step mechanism for pentasaccharide binding and activation of antithrombin-
Together, the similarity in the kinetics of pentasaccharide binding to native and latent antithrombins and in the structures of native, latent and intermediate antithrombin-
pentasaccharide complexes imply a three-step mechanism for pentasaccharide binding and allosteric activation of native antithrombin in which the activating conformational changes occur in two stages (Scheme 2). In steps one and two of the mechanism, the pentasaccharide initially binds with dissociation constant, K 1 , and then induces the first stage conformational changes within the heparin binding site with forward and reverse rate constants, k +2 and k -2 , respectively. In step three, the second stage conformational changes are induced with forward and reverse rate constants, k +3 and k -3 , respectively.
These latter changes involve the extension of helix D and the activating changes in the protease binding site.
Step 1 Step 2
Step . Importantly, this set of rate constants satisfied the rapid equilibrium constraint, k -1 >> k 2 . We then reasoned that to account for the similar limiting rate constants measured for latent and native antithrombin interactions at saturation, k +2 must represent a common rate-limiting conformational change step for the two interactions. We therefore set k +3 for the third step stage II conformational changes to a value much greater (10-fold) than k +2 . We finally constrained k -3 to have a value that would result in a calculated overall equilibrium dissociation constant that corresponded to the measured K D for the native antithrombin interaction given the assumed values for K 1 , k +2 , k -2 and k +3 [29] . It should be noted that the simulations do not depend on the exact values chosen for k +3 and k -3 as long as k +3 >> k +2 and the ratio of k +3 /k -3 is fixed at a value that yields the observed overall dissociation constant for binding. The simulations are also independent of the chosen values for k +1 and k -1 as long as the ratio k -1 /k +1 is fixed at the measured value for K 1 and k -1 >>k +2 so that rapid equilibrium conditions prevail. Table 3 summarizes the rate constants used for the simulations. In this equation, K 1,app is the apparent dissociation constant for the initial binding step and k +lim,app and k -lim,app are apparent forward and reverse rate constants for one or more subsequent rate-limiting conformational change steps. Figure 4 shows that the saturable dependence of k obs on pentasaccharide concentration obtained for the simulations for the native antithrombin interaction resulted in similar fits by the kinetic equation whether the two-step or three-step mechanisms were used. The parameters obtained from these fits shown in Table 4 differ insignificantly (within the experimental error of actual kinetic measurements), indicating that the kinetic data previously interpreted in terms of a two-step mechanism are also fully consistent with the 3-step mechanism.
The simulations of 3-step and 2-step mechanisms for pentasaccharide binding to native and latent antithrombin, respectively, also predict the observed similarity in values for K 1,app and k +lim,app , but differences in values for k -lim,app when these interactions are assumed to have the first two steps in common. k -lim,app , obtained from the intercept of the plots of k obs vs. pentasaccharide concentration ( fig. 4) , represents the overall offrate constant and is equal to k -2 for the two-step latent antithrombin binding mechanism but is approximated by k -2 x k -3 /k +3 for the 3-step native antithrombin mechanism [31] .
The slower off-rate constant for the native as compared to the latent antithrombin interaction thus suggests that the pentasaccharide interaction with the intermediate is conformational changes in the heparin binding site [35] . Importantly, the Lys133Pro mutation resulted in a ~20-fold decrease in heparin binding affinity, comparable to the heparin affinity differences between native and latent antithrombin. Moreover, this decrease in affinity was solely due to an increase in the apparent off-rate constant, the initial binding interaction and the limiting conformational change rate constant that determine the on-rate not being affected at all. This once again parallels the differences 
Increases in pentasaccharide interactions drive antithrombin conformational changes-
Comparison of the salt dependence of pentasaccharide interactions with native and latent antithrombins indicates that the differences in binding affinity result from two fewer ion pair interactions made in the latent antithrombin-pentasaccharide complex than in the native antithrombin complex (Table 2 ) [28] . The contribution of other hydrogen bonding and van der Waals interactions as well as hydrophobic attractions that account for more than half of the binding energy of the native inhibitor interaction are similar for the two complexes [9] . Contrasting our proposal that the stage II conformational changes are driven by improved binding interactions of the pentasaccharide in the fully-activated state, an alternative proposal has suggested that these conformational changes are driven instead by the greater thermodynamic stability of the fully-activated state when the pentasaccharide is bound [26, 27] . However, it is difficult to rationalize this proposal with the fact that the native antithrombin conformation is considerably more thermodynamically stable than the fully-activated conformation, based on the ~5 degree higher melting temperature of native versus activated forms of antithrombin [36, 37] and the equilibrium between these forms that favors the native over the activated state by at least 100:1 [38] . This differential stability reflects the greater stability of antithrombin forms in which the RCL is inserted into sheet A, implying that the intermediate state of
antithrombin in which the RCL is buried in sheet A and the fully-activated state in which the RCL is expelled are likely to have similar differential stabilities. That pentasaccharide binding does not reverse the relative stabilities of these states is indicated by the observation that mutations of positively charged heparin binding site residues to neutral or negatively charged residues which could be considered to mimic pentasaccharide binding fail to activate antithrombin [39] . It thus seems more likely that the stage II conformational changes are intrinsically unfavorable and are driven by the coupling of these changes to changes in the heparin binding site, i.e., helix D extension, that result in an improved fit of the pentasaccharide in the site. That there is an energetic cost to inducing the second stage conformational changes that is paid for by increases in pentasaccharide binding energy is supported by the observation that changes in antithrombin structure that reduce this energetic cost enhance heparin binding affinity [38, 40] . Table 1 for 2-step mechanisms. For the 3-step native antithrombin binding mechanism, kinetic constants for the first two steps were assumed to be identical to those for the latent antithrombin interaction. Kinetic constants for the third step were chosen to make k +3 >> k +2 and to constrain k -3 /k +3 to a value that yielded an overall K D equal to that for the 2-step native antithrombin mechanism. K D was calculated from individual rate constants based on the equations given in Methods. Since the assumed rate constants conform to the conditions, k -1 >> k +2 , k +3 >> k +2 , and k +2 >> k -2 , k on is approximated by k +2 /K 1 for both 2-and 3-step mechanisms and k off is approximated by k -2 for the 2-step mechanism and k -2 x k -3 /k +3 for the 3-step mechanism [31] . 
Conclusions
